Annotation Detail for STX7

Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa04145 | Phagosome |
hsa04130 | SNARE interactions in vesicular transport |
Pathway ID | Pathway Name |
---|
| Botulinum neurotoxicity |
Pathway ID | Pathway Name |
---|
P00001 | Adrenaline and noradrenaline biosynthesis |
P00049 | Parkinson disease |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in increased expression of STX7 mRNA | increases expression | 19417177 20406850
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of STX7 mRNA | affects expression | 16483693
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of STX7 mRNA | decreases expression | 15336504
|
D006220 |
Haloperidol |
Haloperidol results in decreased expression of STX7 mRNA | decreases expression | 15860345
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of STX7 mRNA | increases expression | 19101580
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
4.02 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.30 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.10 | 18287403 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.85 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.86 | 17497229 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
2.34 | 19368416 18080171 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.34 | 18177632 15238991 20603192 18985861 18396377 17157402 19232924 17507914 19460635 17688650 16609825 18316065 18940202 18558336 18775368 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.23 | 20046352 17594078 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.61 | 8888407 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
1.79 | 16705839 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
5.45 | 15215559 1977408 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
3.00 | 6135515 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.81 | 20734317 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.90 | 8888407 16575769 17688650 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.50 | 18551238 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
5.25 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
4.95 | 11575062 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
4.21 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
4.21 | 19641884 1733752 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.45 | 1851702 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.64 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.53 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.09 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.91 | 7562514 6254150 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.78 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.60 | 3659116 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
3.67 | 19224547 14986274 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.50 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.57 | 18558336 8888407 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.41 | 17688650 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
3.28 | 16705839 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.19 | 17596541 16294345 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
2.25 | 7678174 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.74 | 2876784 2876786 6135515 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.87 | 17228818 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
4.55 | 16856516 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.44 | 18765137 18803445 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.40 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.33 | 17596541 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.40 | 18551238 7678174 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.34 | 16359493 8888407 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.78 | 16049721 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.37 | 20603192 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
5.15 | 12752131 11422049 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
5.44 | 11575062 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
4.50 | 11575062 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.58 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
3.99 | 18513383 19369910 1830565 20107430 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
3.99 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.72 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
6.72 | 11044598 11738929 3137016 14763951 1511512 16876388 15475178 17978042 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
2.83 | 8532709 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
4.06 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
5.15 | 12833885 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
5.15 | 20210726 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.85 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
5.06 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
2.40 | 16049721 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
5.13 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.86 | 10091137 |